Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Sulfamonomethoxine sodium

Related Products

Hot Products

Basic Information Post buying leads Suppliers
Name

Sulfamonomethoxine sodium

EINECS N/A
CAS No. 38006-08-5 Density N/A
PSA 106.79000 LogP 2.38900
Solubility N/A Melting Point N/A
Formula C11H12N4NaO3S Boiling Point 513.2 °C at 760 mmHg
Molecular Weight 303.05 Flash Point 264.2 °C
Transport Information N/A Appearance N/A
Safety Risk Codes N/A
Molecular Structure Molecular Structure of 38006-08-5 (Sulfamonomethoxine sodium) Hazard Symbols N/A
Synonyms

Benzenesulfonamide,4-amino-N-(6-methoxy-4-pyrimidinyl)-, monosodium salt (9CI);Sodiumsulfamonomethoxine;Sulfamonomethoxine sodium salt;4-Methoxy-6-sulfanilamidopyrimidine sodium salt;

 

Sulfamonomethoxine sodium Specification

This product is an organic compound with the formula C11H12N4NaO3S. The systematic name of this chemical is Benzenesulfonamide,4-amino-N-(6-methoxy-4-pyrimidinyl)-, sodium salt (1:1). With the CAS registry number 38006-08-5, it is also named as 4-Methoxy-6-sulfanilamidopyrimidine sodium salt. In addition, the molecular weight is 303.05. Its classification code is Drug / Therapeutic Agent. It is a long acting sulfonamide antibacterial agent.

Physical properties of Benzenesulfonamide,4-amino-N-(6-methoxy-4-pyrimidinyl)-, sodium salt (1:1) are: (1)ACD/LogP: -0.04; (2)# of Rule of 5 Violations: 0; (3)#H bond acceptors: 7; (4)#H bond donors: 3; (5)#Freely Rotating Bonds: 3; (6)Polar Surface Area: 84.01 Å2; (7)Flash Point: 264.2 °C; (8)Enthalpy of Vaporization: 78.46 kJ/mol; (9)Boiling Point: 513.2 °C at 760 mmHg; (10)Vapour Pressure: 1.2E-10 mmHg at 25°C.

You can still convert the following datas into molecular structure:
(1)SMILES: [Na+].O=S(=O)(Nc1ncnc(OC)c1)c2ccc(N)cc2
(2)Std. InChI: InChI=1S/C11H12N4O3S.Na/c1-18-11-6-10(13-7-14-11)15-19(16,17)9-4-2-8(12)3-5-9;/h2-7H,12H2,1H3,(H,13,14,15);/q;+1
(3)Std. InChIKey: QHALTWCNEVUKBB-UHFFFAOYSA-N

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
chicken LD50 intravenous 1380mg/kg (1380mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: FOOD INTAKE (ANIMAL)

LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA
Oyo Yakuri. Pharmacometrics. Vol. 9, Pg. 133, 1975.
chicken LD50 oral 7250mg/kg (7250mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: FOOD INTAKE (ANIMAL)

LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA
Oyo Yakuri. Pharmacometrics. Vol. 9, Pg. 133, 1975.
dog LD50 intravenous 792mg/kg (792mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

GASTROINTESTINAL: NAUSEA OR VOMITING

LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA
Oyo Yakuri. Pharmacometrics. Vol. 9, Pg. 133, 1975.
mouse LD50 intraperitoneal 1070mg/kg (1070mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 58, Pg. 59, 1962.
mouse LD50 intravenous 1010mg/kg (1010mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 58, Pg. 59, 1962.
mouse LD50 oral 3240mg/kg (3240mg/kg)   Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 58, Pg. 59, 1962.
mouse LD50 subcutaneous 1gm/kg (1000mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 58, Pg. 59, 1962.
rabbit LD50 intravenous 1530mg/kg (1530mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
Oyo Yakuri. Pharmacometrics. Vol. 9, Pg. 133, 1975.
rat LD50 intravenous 1710mg/kg (1710mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: IRRITABILITY

LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA
Oyo Yakuri. Pharmacometrics. Vol. 9, Pg. 133, 1975.
rat LD50 oral 5620mg/kg (5620mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: IRRITABILITY

LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA
Oyo Yakuri. Pharmacometrics. Vol. 9, Pg. 133, 1975.
rat LD50 subcutaneous 1730mg/kg (1730mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: IRRITABILITY

LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA
Oyo Yakuri. Pharmacometrics. Vol. 9, Pg. 133, 1975.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 38006-08-5